Tinzaparin
Showing 26 - 50 of 227
Cancer Associated Thrombosis for Rivaroxaban - United States
Completed
- Treatment of Venous Thromboembolism in Cancer Patients
- Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, ConnecticutMany Locations
May 18, 2022
Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism Trial in Hong Kong (Dabigatran etexilate, Tinzaparin)
Unknown status
- Venous Thromboembolism
- +2 more
- Dabigatran etexilate
- Tinzaparin
-
Hong Kong, Hong KongThe University of Hong Kong
Apr 15, 2019
COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml
Recruiting
- COVID-19 Severe Respiratory Failure
- Dexamethasone
- +5 more
-
Alexandroupolis, Evros, GreeceUniversity Hospital of Alexandroupolis
Mar 11, 2022
Bioaccumulation of Tinzaparin in Renally Impaired Patients When
Completed
- Renal Insufficiency, Chronic
- Deep Venous Thrombosis, Protection Against
- Tinzaparin
-
Montreal, Quebec, CanadaMaisonneuve-Rosemont Hospital
Dec 12, 2018
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Arterial Occlusion Trial in Thessaloníki (low molecular weight heparin)
Completed
- Arterial Occlusion
- low molecular weight heparin
-
Thessaloníki, Greece1st Cardiology Department, University General Hospital AHEPA
Jul 28, 2021
After Tissue Glue for Gastric Varices
Recruiting
- Anticoagulants and Bleeding Disorders
- +2 more
- Low molecular weight heparin
-
Jinan, Shandong, ChinaDepartment of Gastroenterology,Qilu Hospital,Shandong University
Sep 15, 2022
Severe Fever With Thrombocytopenia Syndrome Trial in China (Methylprednisolone, intravenous immunoglobulin, Tocilizumab)
Recruiting
- Severe Fever With Thrombocytopenia Syndrome
- Methylprednisolone
- +4 more
-
Guangshui, Hubei, China
- +9 more
Oct 31, 2022
Gather Information About Rivaroxaban in Sweden With Cancer Who
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Multiple Locations, Many Locations, SwedenSwedish registries
Aug 18, 2022
Blood Clot, Trauma Trial in Canada, United States (Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH))
Completed
- Blood Clot
- Trauma
- Acetylsalicylic acid
- Low Molecular Weight Heparin (LMWH)
-
Tucson, Arizona
- +20 more
Oct 7, 2022
BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control
Recruiting
- Recurrent Spontaneous Abortion
- Low molecular weight heparin
-
Shanghai, Shanghai, ChinaRenji Hospital, Shanghai Jiaotong University School of Medicine
May 18, 2023
The Clinical Features and Pregnancy Outcomes of CTD Patients
Recruiting
- Connective Tissue Diseases
- Pregnancy Related
- Prednisone
- +3 more
-
Jinan, Shandong, ChinaQilu Hospital
Sep 26, 2022
SARS-COV2 Infection, COVID-19 Disease, Hospitalized Patients Trial in Ioánnina (low molecular weight Heparin as standard of care
Completed
- SARS-COV2 Infection
- +2 more
- low molecular weight Heparin as standard of care treatment
-
Ioánnina, Epirus, GreeceUniversity General Hospital of Ioannina
Sep 27, 2021
Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular
Recruiting
- Cirrhosis
- +3 more
- Apixaban 2.5 MG
- +2 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College, Yangzhou University
Apr 30, 2022
4TS RAM in Prevention of Venous Thromboembolism in Plasma Cell
Recruiting
- Multiple Myeloma
- Venous Thromboembolism
- No intervention
-
Athens, Attica, GreeceAlexandra Hospital , Department of Clinical Therapeutics
Apr 27, 2021
Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Recruiting
- Cancer
- Atrial Fibrillation
- Low molecular weight heparin
-
Thessaloniki, Greece
- +1 more
Feb 14, 2022
Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or
Recruiting
- Covid19
- Anticoagulation Agents (Edoxaban and/or high dose LMWH)
- Low dose Low molecular weight heparin or Placebo
-
Aachen, Germany
- +9 more
May 16, 2022
COVID-19 Pneumonia Trial in Jinan (Bevacizumab)
Recruiting
- COVID-19 Pneumonia
- Bevacizumab
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 13, 2023
Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR) Trial in Germany (5-fluorouracil and low
Completed
- Rhegmatogenous Retinal Detachment
- High-risk for Proliferative Vitreoretinopathy (PVR)
- 5-fluorouracil and low molecular weight heparin
- Placebo
-
Freiburg, BW, Germany
- +12 more
Apr 4, 2022
Acute Coronary Syndrome Trial (A-Phase: tirofiban; Z-Phase simvastatin, Duration of Treatment: A-Phase: minimum suggested 48
Completed
- Acute Coronary Syndrome
- A-Phase: tirofiban; Z-Phase simvastatin
- +4 more
- (no location specified)
Feb 7, 2022
COVID-19 Trial in Toronto (Therapeutic Anticoagulation)
Completed
- COVID-19
- Therapeutic Anticoagulation
-
Toronto, Ontario, CanadaSt. Michael's Hospital
Oct 22, 2021
COVID, Coronavirus Infection, Severe Acute Respiratory Syndrome Trial in São Paulo (Therapeutic anticoagulation)
Completed
- COVID
- +4 more
- Therapeutic anticoagulation
-
São Paulo, SP, BrazilHospital das Clínicas da FMUSP
Oct 25, 2021
Nephrotic Syndrome, Thromboembolic Disease Trial in Aarhus (Dalteparin, Apixaban)
Recruiting
- Nephrotic Syndrome
- Thromboembolic Disease
-
Aarhus, DenmarkAarhus University Hospital
May 20, 2022
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022